Toronto, Ontario, CA
As Medical Science Liaison (MSL) for our cardiometabolic portfolio, you will be a strategic field‑based partner, building credible scientific relationships with Key Opinion Leaders (KOLs), academic institutions, payers and clinical investigators. You will translate Novo Nordisk's medical strategy into impactful engagement that elevates the standard of cardiometabolic care in Canada.